Organization Profile

You just read:

Results from Phase III Pooled EINSTEIN Studies Reaffirm Bayer's Xarelto® as an Effective Single-Drug Solution for Venous Thromboembolism

News provided by

Bayer HealthCare

Sep 20, 2013, 09:58 ET